Slides
Page 1
31.07.2026 Investor Relations Analyst presentation Second Quarter / First Half Year Results 2026
Page 2
Investor Relations, 31.07.2026 Disclaimer Second Quarter / First Half Year Results 20262 This presentation contains certain statements that are neither reported financial results nor other historical information. This presentation also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, geopolitical dislocation, currency fluctuations, the behavior of other market participants, the actions of governmental regulators, and other risk factors, such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company’s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social, and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation, and consumer confidence, on a global, regional, or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.
Page 3
Group performance
Page 4
Investor Relations, 31.07.2026 Second Quarter 2026 Second Quarter / First Half Year Results 20264 1 FCF (Last Twelve Months) defined as cash generated from operating activities – Capex (investments in PPE and IA) 2 Defined as FCF / EBITDA 3 CC = Care Chemicals; CA = Catalysts; AA = Adsorbents & Additives 4 EBITDA before exceptionals Q2 2026: CHF 171.1 m (18.2 %); Q2 2025: CHF 168.5 m (17.4 %) Key messages Sales of CHF 941.3 m – up 0.6 % in local currency on comparable basis, driven by strong value-based pricing across the entire portfolio – marginal LC decline (0.3 %) including pruning – CA impacted by Middle East EBITDA b.e.i.4 margin 80 bps higher driven by strong CC performance (volume and price) offsetting lower volume in CA 15 % pts FCF conversion improvement (Q2 LTM) achieved through effective net working capital management, disciplined capex, and improved operating cash flow Guidance FY 2026 remains unchanged with continued uncertainty and volatility related to Middle East conflict Court dismisses Shell’s damage claim related to the 2020 competition law infringement 52 % vs. 37 % in Q2 2025 (LTM) - 0.3 % vs. Q2 2025 18.2 % vs. 17.4 % in Q2 2025 EBITDA b.e.i. margin
Page 5
Investor Relations, 31.07.2026 Q2 sales:1 CC2 and AA with strong pricing and (underlying) volume growth – CA volumes impacted by Middle East conflict Second Quarter / First Half Year Results 20265 967.7 967.7 964.4 964.4 964.4 941.3 941.3 Q2 2025 + 3.0 % Price - 3.3 % Volume 0.0 % Scope Currency3 Q2 2026 + 0.6 % LC excl. portfolio pruning - 0.3 % LC reported - 2.4 % Care Chemicals + 3.7 % Catalysts + 0.9 % Adsorbents & Additives + 3.3 % Care Chemicals - 1.2 % excl. portfolio pruning + 0.5 % Catalysts - 14.2 % Adsorbents & Additives + 2.0 % Main movers included INR, EUR, USD, and JPY vs. reporting currency CHF No impact 1 All references to local currency growth, pricing, volumes, and scope exclude the price impact from hyperinflation country Türkiye. 2 CC = Care Chemicals; CA = Catalysts; AA = Adsorbents & Additives 3 Currency translation impact includes the price impact from hyperinflation country Türkiye.
Page 6
Investor Relations, 31.07.2026 Second Quarter / First Half Year Results 20266 Q2 EBITDA b.e.i.:1 strong performance in Care Chemicals more than offset Middle East impact in Catalysts + 170 bps Care Chemicals - 70 bps Catalysts - 10 bps Adsorbents & Additives - 10 bps Corporate Q2 2026 b.e.i. 171.1 168.5 Q2 2025 b.e.i. Margin + 80 bps 17.4 % 1 EBITDA before exceptional items Contribution of performance improvement program and cost productivity 18.2 % Strong pricing and higher underlying volume growth supported by favorable valuation effect on inventory Middle East conflict impact (volumes), operating leverage, and higher raw material costs Stable vs. high comparable base as pricing and volume offset higher raw material costs
Page 7
Investor Relations, 31.07.2026 Performance improvement programs (Investor Day 2024) increased by CHF 20 million to deliver CHF 100 m by 2027 Second Quarter / First Half Year Results 20267 Programs – Savings: CHF 100 m total run-rate savings targeted of which CHF 69 m savings achieved, CHF 10 m savings in Q2 – Restructuring: CHF 93 m total restructuring charges (CHF 24 m in Q2) Key measures Q2 2026 – Headcount reduction of ~ 110 FTEs announced – total of ~ 640 FTEs announced – Additional targeted cost management initiatives implemented across the BUs and Corporate functions 80 20 Investor Day 2024 Response 2026 2025 2026 2027 Run-rate savings of CHF 100 m through BU and Corporate actions by 2027 with 90 % contribution already to be achieved by FY 2026 Key levers: • SG&A reduction • Footprint optimization • Operational efficiency • Procurement programs FY 2025: CHF 50 m 1 CC = Care Chemicals; CA = Catalysts; AA = Adsorbents & Additives Q1: CHF 9 m Q2: CHF 10 m Increased targeted cost savings in BUs and Corporate functions
Page 8
Investor Relations, 31.07.2026 Assessment of Middle East (ME) – Operations resumed: All 150 employees are safe, and all Clariant sites (Bahrain, Qatar, UAE, Israel, and Saudi Arabia JV) resumed operations. Globally, feedstock access is secured across the entire global production footprint – Successful value-based pricing: During Q2 2026, pricing increased by 3.0 % overall and was positive across all businesses, enabling Clariant to offset the impact of an inflationary raw material environment which is expected to sequentially ease in H2 – Resilient volumes: Main impact on Catalysts with ME representing around two-thirds of the 14.2 % YoY decline due to order delays; Limited pre-buying in Care Chemicals and in Adsorbents & Additives – Manageable business impact: Clariant customers slowly resuming operations outside the region. Improvement expected into H2 with volatility remaining and force majeures / shutdowns to continue – Profitability guidance underpinned: Additional CHF 20 million cost savings identified as a result of active, targeted cost management supporting to offset impact of conflict 8 Second Quarter / First Half Year Results 2026
Page 9
Q2 2026 Business performance
Page 10
Investor Relations, 31.07.2026 Second Quarter 2026 Care Chemicals Second Quarter / First Half Year Results 202610 – Price: Strong increase as value-based pricing offsetting inflationary trends related to the Middle East and related time-lag of formula-based prices – Volume: Underlying growth (+ 0.5 %) delivered by all segments except Crop Solutions (high comparison base) and Base Chemicals; strongest growth in Personal & Home Care and Industrial Applications – EBITDA b.e.i. margin:2 up 310 bps from increased pricing and underlying growth supported by favorable valuation effect on inventory and contribution from performance improvement programs – Middle East impact for 2026: elevated raw material costs to continue despite sequential slight easing in H2; uncertainty around destocking in H2; regional Oil Services demand shifts; leveraging of global footprint for customers Strong underlying growth driven by consumer facing segments 496.9 509.3 503.7 503.7 Q2 2025 + 3.7 % Price - 1.2 % Volume 0.0 % Scope - 1. 1 % Currency / HIA Q2 2026 + 4.2 % LC excl. portfolio pruning + 2.5 % LC reported + 1.4 % 87.5 104.2 Q2 2025 b.e.i. Q2 2026 b.e.i. + 310 bps Sales1 (in CHF m) 17.6 % 20.7 % In LC Sales Q2 20263 Personal & Home Care HSD + Crop Solutions DD - Industrial Applications DD + Base Chemicals LSD - Oil Services MSD -4 Mining Solutions LSD + EBITDA b.e.i.2 (margin) Segments 1 Currency translation impact includes the price impact from hyperinflation country Türkiye. 2 Before exceptional items 3 LSD = low single-digit; MSD = mid-single-digit; HSD = high single-digit. 4 LSD up, excluding portfolio pruning
Page 11
Investor Relations, 31.07.2026 1 Currency translation impact includes the price impact from hyperinflation country Türkiye. 2 Before exceptional items 3 DD = double-digit Second Quarter 2026 Catalysts Second Quarter / First Half Year Results 202611 – Price: slightly up in all segments – Volume: significant Middle East impact as predicted with high-margin orders (DD m) being delayed; Specialties with strong growth in hydrogenation and oxidation catalysts – EBITDA b.e.i. margin:2 down 370 bps due to Middle East impact, lower operating leverage, and higher raw materials (MSD %) vs. elevated prior year – Middle East impact for 2026: continued delays of refill orders in the Middle East and Asia; normalization in H2 expected as customers outside the Middle East resume operations; inflationary raw materials impact Lower volumes due to ME impact, high margin comparable 217.9 217.9 189.1 189.1 189.1 176.2 176.2 Q2 2025 + 0.9 % Price - 14.2 % Volume 0.0 % Scope - 5.8 % Currency / HIA Q2 2026 - 13.3 % - 19.1 % 48.6 32.8 Q2 2025 b.e.i. Q2 2026 b.e.i. - 370 bps EBITDA b.e.i.1 (margin) 22.3 % 18.6 % In LC Sales Q2 20263 Propylene DD - Ethylene DD - Syngas & Fuels DD - Specialties DD + Segments Sales1 (in CHF m)
Page 12
Investor Relations, 31.07.2026 1 Currency translation impact includes the price impact from hyperinflation country Türkiye. 2 Before exceptional items 3 LSD = low single-digit; DD = double-digit Strong top-line driven by Additives (price and volume) Second Quarter 2026 Adsorbents & Additives Second Quarter / First Half Year Results 202612 – Price: up in all segments to offset inflationary raw materials (HSD %) since start of Middle East conflict – Volume: strongly up in Additives driven by Polymer Solutions (Flame Retardants) and Coatings & Adhesives; Adsorbents flat with growth in renewable fuel applications in the United States offsetting declines in edible oil purification in other regional segments – EBITDA b.e.i. margin:2 slightly lower due to mix effects almost compensated by active margin management and performance improvement programs – Middle East impact for 2026: limited direct impact with uncertainty around destocking and global consumer demand in H2; inflationary raw materials to be offset via value-based pricing 252.9 252.9 261.3 266.4 266.4 261.4 261.4 Q2 2025 + 3.3 % Price + 2.0 % Volume 0.0 % Scope - 1.9 % Currency / HIA Q2 2026 + 5.3 % + 3.4 % 50.5 51.2 Q2 2025 b.e.i. Q2 2026 b.e.i. - 40 bps 20.0 % 19.6 % In LC Sales Q2 20263 Adsorbents (51 %) Flat Additives (49 %) DD + EBITDA b.e.i.1 (margin) Segments (split) Sales (in CHF m)
Page 13
Investor Relations, 31.07.2026 First Half Year 2026 Second Quarter / First Half Year Results 202613 1 FCF (Last Twelve Months) defined as cash generated from operating activities – Capex (investments in PPE and IA) 2 Defined as FCF / EBITDA 3 CC = Care Chemicals; CA = Catalysts; AA = Adsorbents & Additives 4 EBITDA before exceptionals H1 2026: CHF 331.3 m (17.8 %); H1 2025: CHF 358.9 m (18.1 %) Key messages – Sales of CHF 1 859.3 m – Flat in LC excluding portfolio pruning ➔ Middle East volume impact in CA3, offset by underlying volume growth in CC and flat AA, Pricing (+ 0.7 %) up in all businesses, currencies negative 4.9 % – EBITDA b.e.i. margin at 17.8 % with improvement in CC offsetting lower CA; reported EBITDA of CHF 300.2 m (16.1 %) improved due to lower restructuring charges – Cash generated from operating activities increased by CHF 52.8 m and FCF conversion improved to 52 % vs. 37 % ➔ active net working capital management and disciplined capex – Group net debt increased by CHF 79.2 m vs. full year 2025; net debt / LTM EBITDA b.e.i. increased to 2.2 x vs. FY 2025 net debt / LTM EBITDA b.e.i. 2.0 x 52 % vs. 37 % in H1 2025 (LTM) - 1.2 % vs. H1 2025 17.8 % vs. 18.1 % in H1 2025 EBITDA b.e.i. margin
Page 14
Group Outlook
Page 15
Investor Relations, 31.07.2026 ~ flat sales growth in local currency1 (CHF 3.915 b in 2025; flat vs. PY) Guidance 2026 remains unchanged in challenging and volatile market environment impacted by Middle East conflict Second Quarter / First Half Year Results 202615 2026 guidance (Q1) ~ 18.0 % EBITDA margin before exceptional items External factors – Middle East (ME) conflict with continued geopolitical challenges, uncertainties, and risks → negative impact mainly on CA and on ME Oil Services in CC – Global GDP growth stable at 2.5 % (vs. 2.4 % in April), global chemical industry growth slightly higher 1.0 % (from 0.4 % in April) – No easing of interest rates; long-term rates remain elevated Internal factors – Portfolio pruning impact of negative ~ 1 % (Group) and ~ 2 % (CC) 2 – Growth in AA; slight growth in CC (underlying); CA expected lower (ME) – Value-based pricing to offset increased inflationary effects and volume impacts – Leveraging of global network to provide continued supply to customers ~ flat sales growth in local currency1 2026 guidance (Q2) ~ 18.0 % EBITDA margin before exceptional items – Deliver cost savings of increased performance improvement programs – Increase in raw materials, energy, and logistic costs (pass-through) – General inflation ~ 3 - 4 %, driven by wages 1 All references to local currency exclude the price impact from hyperinflation country Türkiye; 2 CC = Care Chemicals; CA = Catalysts; AA = Adsorbents & Additives Clariant remains committed to medium-term targets, delivered by 2027 at the latest (17.8 % in 2025; up 180 bps vs PY)
Page 16
Appendix
Page 17
Investor Relations, 31.07.2026 Modeling guidance FY 2026 versus FY 2025 17 Second Quarter / First Half Year Results 2026 Portfolio pruning • Divestments and closures create a negative top-line impact of 1 % (Group) and 2 % (Care Chemicals) to 2026 sales Sales guidance • Growth in Adsorbents & Additives • Slight underlying growth in Care Chemicals (catching up portfolio pruning effect) • Catalysts expected lower (Middle East postponements of refill activities) FX assumption • ~ 3 – 5 % headwind on sales (FY) Raw materials / energy / logistics • High single-digit percent up / high single-digit percent up / double- digit percent up Performance improvement programs (Investor Day 2024) • CHF 69 m of CHF 100 m targeted run-rate cost savings achieved as of HY2026; Total expectation of CHF 90 million in FY2026, with remainder expected in 2027 Capex • Targeted at CHF 150 m – 175 m Tax rate • 27 – 29 %
Page 18
Investor Relations, 31.07.2026 Second Quarter 2026 – Overview 18 Second Quarter / First Half Year Results 2026 in CHF m Q2 2026 Q2 2025 % CHF % LC1 Sales 941.3 967.7 - 2.7 - 0.3 EBITDA 142.4 138.5 2.8 EBITDA margin 15.1 % 14.3 % EBITDA b.e.i.2 171.1 168.5 1.5 EBITDA b.e.i.2 margin 18.2 % 17.4 % Sales Bridge Price1 3.0 % Volume1 - 3.3 % Scope1 0.0 % Currency - 2.4 % Group Care Chemicals Catalysts Adsorbents & Additives in CHF m Q2 2026 Q2 2025 % CHF % LC1 Sales 503.7 496.9 1.4 2.5 EBITDA 96.7 67.1 44.1 EBITDA margin 19.2 % 13.5 % EBITDA b.e.i.2 104.2 87.5 19.1 EBITDA b.e.i.2 margin 20.7 % 17.6 % Sales Bridge Price1 3.7 % Volume1 - 1.2 % Scope1 0.0 % Currency - 1.1 % Sales Split Consumer 59 % Industrial 41 % in CHF m Q2 2026 Q2 2025 % CHF % LC1 Sales 176.2 217.9 - 19.1 - 13.3 EBITDA 27.9 47.8 - 41.6 EBITDA margin 15.8 % 21.9 % EBITDA b.e.i.2 32.8 48.6 - 32.5 EBITDA b.e.i.2 margin 18.6 % 22.3 % Sales Bridge Price1 0.9 % Volume1 - 14.2 % Scope1 0.0 % Currency - 5.8 % Sales Split Petrochemicals 36 % Syngas 32 % Specialties 32 % in CHF m Q2 2026 Q2 2025 % CHF % LC1 Sales 261.4 252.9 3.4 5.3 EBITDA 44.7 47.0 - 4.9 EBITDA margin 17.1 % 18.6 % EBITDA b.e.i.2 51.2 50.5 1.4 EBITDA b.e.i.2 margin 19.6 % 20.0 % Sales Bridge Price1 3.3 % Volume1 2.0 % Scope1 0.0 % Currency - 1.9 % Sales Split Consumer 50 % Industrial 50 % Additives 49 % Adsorbents 51 % 1 All references to local currency growth, pricing, volumes, and scope exclude the price impact from hyperinflation country Türkiye; 2 Before exceptional items
Page 19
Investor Relations, 31.07.2026 First Half Year 2026 – Overview 19 Second Quarter / First Half Year Results 2026 in CHF m H1 2026 H1 2025 % CHF % LC1 Sales 1 859.3 1 980.7 - 6.1 - 1.2 EBITDA 300.2 291.1 3.1 EBITDA margin 16.1 % 14.7 % EBITDA b.e.i.2 331.3 358.9 - 7.7 EBITDA b.e.i.2 margin 17.8 % 18.1 % Sales Bridge Price1 0.7 % Volume1 - 1.9 % Scope1 0.0 % Currency - 4.9 % Group Care Chemicals Catalysts Adsorbents & Additives in CHF m H1 2026 H1 2025 % CHF % LC1 Sales 1 050.3 1 095.8 - 4.2 0.1 EBITDA 210.4 183.9 14.4 EBITDA margin 20.0 % 16.8 % EBITDA b.e.i.2 218.8 216.9 0.9 EBITDA b.e.i.2 margin 20.8 % 19.8 % Sales Bridge Price1 0.2 % Volume1 - 0.1 % Scope1 0.0 % Currency - 4.3 % Sales Split Consumer 61 % Industrial 39 % in CHF m H1 2026 H1 2025 % CHF % LC1 Sales 318.8 380.2 - 16.1 - 8.3 EBITDA 39.9 71.6 - 44.3 EBITDA margin 12.5 % 18.8 % EBITDA b.e.i.2 45.6 75.0 - 39.2 EBITDA b.e.i.2 margin 14.3 % 19.7 % Sales Bridge Price1 0.7 % Volume1 - 9.0 % Scope1 0.0 % Currency - 7.8 % Sales Split Petrochemicals 36 % Syngas 34 % Specialties 30 % in CHF m H1 2026 H1 2025 % CHF % LC1 Sales 490.2 504.7 - 2.9 1.3 EBITDA 87.3 83.7 4.3 EBITDA margin 17.8 % 16.6 % EBITDA b.e.i.2 93.8 97.4 - 3.7 EBITDA b.e.i.2 margin 19.1 % 19.3 % Sales Bridge Price1 1.5 % Volume1 - 0.2 % Scope1 0.0 % Currency - 4.2 % Sales Split Consumer 50 % Industrial 50 % Additives 48 % Adsorbents 52 % 1 All references to local currency growth, pricing, volumes, and scope exclude the price impact from hyperinflation country Türkiye; 2 Before exceptional items
Page 20
Investor Relations, 31.07.2026 First Half Year 2026 – Consolidated Income Statement Second Quarter / First Half Year Results 202620 Highlights – Gross margin improved to 31.5 %, strong pricing vs. higher energy and raw materials – Selling, general, and administrative costs decreased by ~ 12 %, driven by performance programs and cost productivity compensating for inflation – Investments in R&D stable at 3.4 % of sales – Operating income improved due to better cost productivity supported by lower restructuring and impairments – Underlying tax rate at 29.1 % vs. 25.6 % in 2025; in line with FY guidance of 27 – 29 % – Net income increased mainly attributable to higher operating income and slightly improved net financial result offsetting higher taxes H1 2026 H1 2025 CHF m % CHF m % Sales 1 859.3 100.0 1 980.7 100.0 Costs of goods sold - 1 274.3 - 1 393.4 Gross profit 585.0 31.5 587.3 29.7 Selling, general, and administrative costs - 356.5 - 404.0 Research and development costs - 64.1 - 66.6 Income from associates and joint ventures 18.5 21.4 Operating income 182.9 9.8 138.1 7.0 Finance income 5.9 8.3 Finance costs - 52.6 - 56.2 Income before taxes 136.2 7.3 90.2 4.6 Taxes - 51.2 - 46.0 Net income 85.0 4.6 44.2 2.2 1 CTA = cumulative translation adjustments
Page 21
Investor Relations, 31.07.2026 First Half Year 2026 – Cash Flow Statement Second Quarter / First Half Year Results 202621 Highlights – Net cash generated from operating activities increased by > CHF 50 m driven by improved profitability and effective net working capital management – Disciplined Capex with usual H2 acceleration expected – Free cash flow (FCF1) of CHF 123.8 m increased from CHF 54.8 m in the prior year mainly due to execution of cash initiative, higher profitability and disciplined Capex – FCF conversion2 (June 2026 LTM) of 52 % vs. 37 % in the prior year – Net cash used in investing and generated from financing activities driven by Capex and refinancing activities 1 Defined as cash generated from operating activities – Capex (investments in PPE and IA) 2 Defined as FCF / EBITDA, as FCF is defined as cash generated from operating activities – Capex (investments in PPE and IA) CHF m H1 2026 H1 2025 Net income 85.0 44.2 Adjustment for: Depreciation and amortization 117.1 122.8 Impairment of property, plant, and equipment and intangible assets 0.2 30.2 Impairment of working capital 8.8 7.6 Income from associates and joint ventures - 18.5 - 21.4 Tax expense 51.2 46.0 Net financial income and costs 32.7 34.4 Gain / loss from the disposal of activities not qualifying as discontinued operations 0.1 - 0.5 Other non-cash items 24.4 13.3 Total reversal of non-cash items 216.0 232.4 Dividends received from associates and joint ventures 45.5 46.3 Payments for restructuring - 26.1 - 22.6 Cash flow before changes in net working capital and provisions 320.4 300.3 Changes in inventories - 190.2 - 127.4 Changes in trade receivables - 10.0 17.5 Changes in trade payables 102.4 - 54.9 Changes in other current assets and liabilities - 6.3 25.0 Changes in provisions (excluding payments for restructuring) - 22.9 11.8 Cash generated from operating activities 193.4 172.3 Income taxes paid - 24.7 - 56.4 Net cash generated from operating activities 168.7 115.9 Investments in property, plant, and equipment - 44.0 - 60.4 Investments in intangible assets - 0.9 - 0.7 Investments in financial assets, associates, and joint ventures - 3.2 - 1.7 Changes in current financial assets and short-term deposits - 14.2 - 126.8 Interest received 5.7 7.0 Proceeds from the disposal of property, plant, and equipment and intangible assets 1.9 10.9 Proceeds from the disposal of activities not qualifying as discontinued operations 0.2 0.5 Net cash used by investing activities - 54.5 - 171.2 Purchase of treasury shares - - Distributions to the shareholders of Clariant Ltd - 138.4 - 138.1 Dividends paid to non-controlling interest - 9.4 - 3.4 Proceeds from financial debts 465.7 279.5 Repayments of financial debts - 367.8 - 85.0 Repayments of lease liabilities - 21.7 - 22.5 Interest paid - 30.3 - 31.1 Interest paid for leases - 4.3 - 4.8 Net cash generated from / used in financing activities - 106.2 - 5.4 Currency translation effect on cash and cash equivalents - 1.8 - 13.6 Net change in cash and cash equivalents 6.2 - 74.3 Cash and cash equivalents at the beginning of the period 410.4 387.9 Cash and cash equivalents at the end of the period 416 6 313.6
Page 22
Investor Relations, 31.07.2026 First Half Year 2026 – Balance Sheet Second Quarter / First Half Year Results 202622 – Total assets increased to CHF 6.048 b mainly due to higher net working capital – Share capital reduced to CHF 305 m due to distribution to shareholders through capital reduction by way of par value reduction – Group net debt of CHF 1.493 b slightly increased, representing a net debt / LTM EBITDA b.e.i. ratio of 2.2 compared to 2.6 a year ago and 2.0 at year end 2025 30.06.2026 31.12.2025 ASSETS CHF m % CHF m % Non-current assets Property, plant, and equipment 1 337.7 1 357.2 Right-of-use assets 167.4 173.3 Intangible assets 1 467.7 1 466.5 Investments in associates and joint ventures 224.2 247.7 Financial assets and other assets 247.9 242.8 Net defined benefit assets 38.6 38.8 Deferred tax assets 103.2 114.9 Total non-current assets 3 586.7 59.3 3 641.2 62.0 Current assets Inventories 833.7 641.2 Trade receivables 629.0 614.2 Other current assets 281.2 260.2 Income tax receivables 63.2 77.1 Short-term deposits 217.8 206.2 Cash and cash equivalents 416.6 410.4 Assets held for sale 20.0 20.2 Total current assets 2 461.5 40.7 2 229.5 38.0 Total assets 6 048.2 100.0 5 870.7 100.0 30.06.2026 31.12.2025 EQUITY AND LIABILITIES CHF m % CHF m % Equity Share capital 305.4 444.8 Treasury shares (par value) - 2.2 - 4.1 Other reserves - 1 267.5 - 1 322.3 Retained earnings 2 982.3 2 905.9 Total capital and reserves attributable to Clariant Ltd shareholders 2 018.0 2 024.3 Non-controlling interests 160.6 157.6 Total equity 2 178.6 36.0 2 181.9 37.2 Liabilities Non-current liabilities Financial debts 1 674.0 1 529.7 Deferred tax liabilities 83.7 84.3 Net defined benefit liability 429.8 426.0 Lease liabilities 125.5 132.4 Other liabilities 1.2 1.2 Provisions 165.0 153.9 Total non-current liabilities 2 479.2 41.0 2 327.5 39.6 Current liabilities Trade payables and other liabilities 761.5 635.9 Financial debts 288.2 329.2 Income tax liabilities 167.4 167.7 Lease liabilities 40.5 39.7 Provisions 130.1 186.1 Liabilities directly associated with assets held for sale 2.7 2.7 Total current liabilities 1 390.4 23.0 1 361.3 23.2 Total liabilities 3 869.6 64.0 3 688.8 62.8 Total equity and liabilities 6 048.2 100.0 5 870.7 100.0
Page 23
Investor Relations, 31.07.2026 Q2 sales CHF 941.3 m in CHF m, % in local currency1 Geographic split Second Quarter / First Half Year Results 202623 Americas 265.1 / - 8.0 % EMEA 399.7 / - 0.2 % Asia-Pacific 276.5 / + 7.8 % Germany 109.6 / + 9.1 % 1 All references to local currency growth, pricing, volumes, and scope exclude the price impact from hyperinflation country Türkiye; 2 BU = Business Unit; CC = Care Chemicals; CA = Catalysts; AA = Adsorbents & Additives; 3 LSD = low single-digit; MSD = mid-single-digit; HSD = high single-digit; DD = double-digit; MDD = mid double-digit 42.4 % 28.2 % 29.4 % BU2 Q2 sales CC MSD + CA DD - AA MSD + BU2 Q2 sales CC HSD + CA MSD + AA DD + BU2 Q2 sales CC LSD - CA MDD - AA Flat China 99.3 / - 8.3 % USA 152.5 / - 6.6 % Brazil 56.7 / - 8.8 % H1 sales CHF 1 859.3 m in CHF m, % in local currency1 Americas 522.2 / - 6.6 % EMEA 800.7 / - 3.9 % Asia-Pacific 536.4 / + 9.2 % Germany 208.5 / - 0.4 % 43.1 % 28.1 % 28.8 % BU2 H1 sales CC Flat CA DD - AA Flat BU2 H1 sales CC MSD + CA DD + AA HSD + BU2 H1 sales CC LSD - CA MDD - AA LSD - China 194.0 / + 0.0 % USA 309.7 / - 0.8 % Brazil 106.7 / - 11.7 %
Page 24
Investor Relations, 31.07.2026 EBITDA / EBIT Bridge First Half Year 2026 Second Quarter / First Half Year Results 202624 1 Depreciation & Impairment Group (CHF m) Care Chemicals (CHF m) Catalysts (CHF m) Adsorbents & Additives (CHF m) 331.3 EBITDA bei - 31.1 Exceptional items EBITDA - 101.2 D&I1 EBITA - 16.1 Amortization EBIT 31.3 Exceptional items EBIT bei 300.2 199.0 182.9 214.2 17.8% 16.1% 10.7% 9.8% 11.5% - 36.8 218.8 EBITDA bei - 8.4 Exceptional items EBITDA D&I1 EBITA - 12.0 Amortization EBIT 8.6 Exceptional items EBIT bei 210.4 173.6 161.6 170.2 20.8% 20.0% 16.5% 15.4% 16.2% -29.0 45.6 EBITDA bei -5.7 Exceptional items EBITDA D&I1 EBITA -2.3 Amortization EBIT 5.7 Exceptional items EBIT bei 39.9 10.9 8.6 14.3 14.3% 12.5% 3.4% 2.7% 4.5% - 27.6 93.8 EBITDA bei - 6.5 Exceptional items EBITDA D&I1 EBITA - 1.6 Amortization EBIT 6.5 Exceptional items EBIT bei 87.3 59.7 58.1 64.6 19.1% 17.8% 12.2% 11.9% 13.2%
Page 25
Investor Relations, 31.07.2026 ROIC vs. cost of capital Second Quarter / First Half Year Results 202625 − Organic growth − Increasing operating margin − Reducing nonoperating cost − Improving capital turns Future improvement drivers ROIC1 in % 1 From continuing operations; 2 Excluding CHF 231 m provision for competition law investigation by the European Commission 3 Excluding impairment charges of CHF 453 million for North American Land Oil divestment and the sunliquid plant 4 Excluding impairment charges and restructuring/exceptional items related to sunliquid decision of CHF 133 million 2019 2020 (restated) 2021 1.5 % (reported) 2022 6.6 % (reported) FY 2023 FY 2024 FY 2025 HY 2026 (LTM) 7.7 % 7.4 % 9.9 % 10.6 % 9.5 % 9.2 % 6.9 % 8.0 % Cost of capital: ~ 8.0 % 2 3 4
Page 26
Investor Relations, 31.07.2026 Second Quarter / First Half Year Results 202626 − Raw materials in Q2 up 7.4 % YoY (sequential up 11.4 %) − Energy in Q2 up 6.0 % YoY (sequential up 3.7 %) − Logistics in Q2 up 8.1 % YoY (sequential down 1.5 %) − Low-growth economic environment with inflationary raw materials, energy, and logistics in Q2 2026 − Q2 Pricing: 3.0 % (sequential 3.8 %) − Q2 Volumes: - 3.3 % (sequential down 1.9 % due to seasonal business in CC) 21 % 25 % 2 % 2 % 7 % 18 % 35 % -5 % 6 % 21 % 6 % FY 21 FY 22 - 20 % - 13 % - 11 % FY 23 - 3 % - 7 % FY 24 - 10 % - 1 % FY 25 - 9 % - 5 % Q1 26 8 % Q2 26 Logistics Energy Raw Materials Cost dynamics – year on year and sequentially mixed Pricing and volumes stable around the flat line 8 % 17 % - 1 % 7 % 7 % - 7 % FY 21 FY 22 0 % FY 23 - 2 % FY 24 - 1 % 0 % FY 25 - 0.5 % - 1.5 % Q1 26 3.0 % - 3.3% Q2 26 Volume Pricing
Page 27
Investor Relations, 31.07.2026 Exposure to attractive consumer markets of close to 50 %... …with accelerating demand for sustainable products Second Quarter / First Half Year Results 202627 Sales by End Market 2021 (Total Group) Sales by End Market Q2 LTM 20261 Industrial 47 % Consumer 36 % Chemical Process (Catalysts) 17 % Other Industrial > 5 % Mining ~ 5 % Aviation < 5 % Building & Construction < 5 % Automotive ~ 10 % Oil ~ 10 % Consumer Home & Personal Care ~ 20 % Coatings & Adhesives ~ 10 % Agriculture & Food < 10 % Electrical & Electronics < 5 % Industrial Industrial 35 % Consumer 45 % Chemical Process (Catalysts) 20 % 1 Last Twelve Months (Q3 2025 – Q2 2026)
Page 28
Investor Relations, 31.07.2026 ESG – Clariant’s sustainability transformation commitment 28 Second Quarter / First Half Year Results 2026 Sustainability priorities Investment in operations and portfolio Zero waste and pollution Eliminating waste and pollution from our operations and value chains Sustainable bio-economy Creating a sustainable bio-economy by protecting nature and maintaining high social standards Increasing circularity Products and solutions that enable reducing, reusing, and recycling Social value creation Creating value for our employees, in our business networks, and in society as a whole Safe and sustainable in everything we do Fighting climate change Reducing our own carbon footprint and creating value for customers with low-carbon, high-performing solutions Sustainable operations Future-proof our operations for a climate- neutral, sustainable world Sustainability-driven portfolio change Increase the safety and sustainability of our products and help our customers achieve their sustainability goals
Page 29
Investor Relations, 31.07.2026 Clariant’s leading sustainability ratings and rankings Second Quarter / First Half Year Results 202629 Status as of March 2026 Index / Ranking / Rating Clariant Score / Percentile Rank or Range Status / Comments First Year of Inclusion 2015AA to A with 2026 Methodology Update (review ongoing)A / Range: AAA to CCC 22.2 (Medium Risk) Climate (CC): A (Range: A to D-) Water (WS): A (Range: A to D-) Forests (F): A (Range: A to D-) Top 10 % of companies in its Specialty Chemicals subindustry Out of 22 000 companies, only 26 earn Triple A status 2016 2013 B- / Top 10 % 3.9 / 73rd Percentile 84 / 99th Percentile 60 / 100 - "Advanced" "Prime" Status and Industry Leader Included in FTSE4 Good Index – 2013 2015 2012 2014 Rank | Percentile Subindustry (Specialty Chemicals) Industry (Chemicals) 70 / 577 | 13th 15 / 155 | 10th 2% 5% 7% 19% 20% 27% 19% CCC B BB BBB A AA AAA A A- B B- C C- D D- – Overall Score 84/ 100
Page 30
Investor Relations, 31.07.2026 Reducing corporate GHG emissions Significant improvement of non-financial KPIs – fully on track to deliver updated 2030 greenhouse gas (GHG) targets Second Quarter / First Half Year Results 202630 New operating model driving customer satisfaction and employee engagement – Safety as #1 priority – Safety ▪ Commitment to achieve a zero-accidents culture ▪ LTM Q2 2026 DART rate at 0.12 vs. 0.13 in FY 2025; lower due to continued high awareness, safety trainings, and accountability ▪ Top-quartile performance in the chemical industry – Employee engagement survey ▪ All employees invited to an engagement survey in Jan. 2026 ▪ Participation rate increased from 86 % to 88 % ▪ Employee engagement at 87 % – top quartile vs. industry peers ▪ Employee engagement score increased to + 37 in 2026 compared to + 34 in 2025 – Customer satisfaction ▪ Customer Net Promoter Score (cNPS) increased to 50 in 2025 vs. 45 in 2024 ▪ Outstanding scores for “product quality,” “technical support,” and “customer service” ▪ Positions Clariant in the top quartile among peers 46.9 % reduction in Scope 1 & 2 emissions 0.75 0.54 0.49 0.43 0.42 0.40 2019 2023 2024 LTM Q2 2026 Target 2030 2025 - 2.3 % Scope 1 & 2 GHG emissions in m tCO2e, corresponding to – 43.6 % since 2019 Scope 3.1 & 3.12 GHG emissions in m tCO2e, corresponding to – 28.9 % since 2019 5.19 4.08 4.01 3.73 3.69 3.76 2019 2023 2024 2025 LTM Q2 2026 Target 2030 - 1.1 % New baseline New baseline In 2024, Clariant performed a rebaselining exercise, reflecting the latest climate science and structural changes to the company since the 2019 baseline was developed. Based on the new baseline, Clariant has updated its near-term company-wide emission reductions to be consistent with the Paris Agreement goals that aim to limit global warming to 1.5°C. The updated near-term targets were reviewed and approved by SBTi in 2025. 27.5 % reduction in Scope 3.1 & 3.12 emissions
Page 31
Investor Relations, 31.07.2026 Calendar of upcoming corporate events Second Quarter / First Half Year Results 202631 31 July 2026 Second Quarter / Half Year 2026 Reporting 3 November 2026 Third Quarter / Nine Month 2026 Reporting 23 February 2027 Fourth Quarter / Full Year 2026 Reporting 7 April 2027 AGM 2027
Page 32
Investor Relations, 31.07.2026 The Executive Leadership Team Second Quarter / First Half Year Results 202632 Conrad Keijzer Chief Executive Officer Executive Leadership Team Executive Steering Committee Jens Cuntze Business President CA & APAC Angela Cackovich Business President AA & EMEA Priya Thaman Chief Human Resources Officer Judith Bischof General Counsel Richard Haldimann Chief Strategy & Technology Officer Marcelo Lu Business President CC & Americas Oliver Rittgen Chief Financial Officer
Page 33
Investor Relations, 31.07.2026 IR contacts Second Quarter / First Half Year Results 202633 ANDREAS SCHWARZWÄLDER Head of Investor Relations Phone: +41 61 469 63 73 Email: investor-relations@clariant.com THIJS BOUWENS Investor Relations Officer Phone: +41 61 469 63 73 Email: investor-relations@clariant.com
Page 34
Thank you We place great value on understanding the current views of our investment community. Therefore, we would greatly appreciate your input and feedback via www.clariant.com/Investors/Feedback. Your information will be collected via the secure platform of QuantiFire, who manages this process on our behalf.